Copyright
©The Author(s) 2024.
World J Psychiatry. Jun 19, 2024; 14(6): 938-944
Published online Jun 19, 2024. doi: 10.5498/wjp.v14.i6.938
Published online Jun 19, 2024. doi: 10.5498/wjp.v14.i6.938
Group | Experiment group (n = 40) | Control group (n = 40) | ||
Before treatment | After treatment | Before treatment | After treatment | |
MoCA total score 30 | 18.25 ± 2.34 | 20.43 ± 2.65 | 17.65 ± 2.16 | 16.53 ± 1.98 |
Memory ability 5 | 2.75 ± 0.81 | 3.15 ± 0.96 | 2.64 ± 0.79 | 2.40 ± 0.73 |
Verbal fluency 3 | 2.13 ± 0.78 | 2.52 ± 0.92 | 2.06 ± 0.77 | 1.97 ± 0.72 |
Visuospatial execution ability 5 | 2.98 ± 0.59 | 3.27 ± 0.70 | 2.87 ± 0.61 | 2.71 ± 0.58 |
Naming capability3 | 2.10 ± 0.81 | 2.30 ± 0.85 | 2.07 ± 0.79 | 1.94 ± 0.77 |
Attention and calculation ability 6 | 3.05 ± 0.78 | 3.42 ± 0.84 | 3.01 ± 0.76 | 2.74 ± 0.72 |
Orientation ability 6 | 4.02 ± 0.89 | 4.45 ± 0.93 | 3.94 ± 0.85 | 3.79 ± 0.81 |
Ability of abstraction and generalization 2 | 1.09 ± 0.45 | 1.31 ± 0.56 | 1.04 ± 0.49 | 0.95 ± 0.42 |
- Citation: Li JB, Jiang J, Xue L, Zhao S, Liu HQ. Clinical efficacy of Baijin pills in the treatment of generalized tonic-clonic seizure epilepsy with cognitive impairment. World J Psychiatry 2024; 14(6): 938-944
- URL: https://www.wjgnet.com/2220-3206/full/v14/i6/938.htm
- DOI: https://dx.doi.org/10.5498/wjp.v14.i6.938